How did Musk-Trump feud impact Tesla stock?
Why will SpaceX decommission its Dragon spacecraft?
What caused Lululemon’s profit forecast cut?
How is US job growth trending in May?
Why is Circle's stock soaring after IPO?
What effect do Trump's tariffs have on jobs?
Why did the US court block Apple's App Store pause?
23andMe Angles For A Bigger Regeneron Bid As Ex-CEO Steps Up With A Better Offer
investors.com/news/technology/23andme-former-ceo-anne-wojcicki-regeneron-pharmaceuticals/?src=A00220
Bankrupt genetics company 23andMe (MEHCQ) wants to reopen bidding on its assets after former Chief Executive Anne Wojcicki put together a $305 million offer, topping Regeneron Pharmaceuticals (REGN).
Regeneron was previously the top bidder at a bankruptcy auction, offering to pay $256…
This story appeared on investors.com, 2025-06-05 14:17:16.